Tag: cancer
-

Patent Awarded for Safer Cancer Drug Delivery
A pharmaceutical R&D company is receiving a patent for its process that encapsulates and better targets chemotherapy drugs for cancer patients.
-

Precision Cancer Meds Company Raises $43M in Early Funds
A company combining computational genetic analysis and precision medicine discovery for cancer therapies is raising $43 million in its first venture round.
-

Small Biz Grant Funds Covid-19 Antiviral Therapy
A biotechnology company developing cancer therapies is receiving an NIH grant to extend its technology for antiviral peptides against the SARS-CoV-2 virus.
-

MD Anderson, Broad Institute Partner on Rare Cancers
MD Anderson Cancer Center and the Broad Institute are developing a new research platform for better understanding rare types of cancer.
-

Biotechs Partner on Gene-Edited Cancer Cell Therapies
Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer.
-

Cell Therapy Mfring Company Raises $82M in Venture Funds
A company developing an automated yet personalized manufacturing platform for cell therapies is raising $82 million in its second venture funding round.
-

AI Drug Discovery Company Acquired in $270M Deal
A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery company based on machine learning algorithms.
-

Microsoft, Biotech Partner on Metastatic Cancer
A biotechnology start-up is collaborating with Microsoft Corp. on computational tools to find and predict factors that cause cancers to spread.
-

Clinical Trial Tests In-Tumor Breast Cancer Therapy
A clinical trial is set to begin that tests a treatment for early-stage breast cancer delivered directly into the tumor before surgery is scheduled.
-

Precision Cancer Immunotherapy Biotech Underway
A new company is beginning work on a safer form of cancer immunotherapy that avoids toxic off-target effects, and raising $55 million in venture funds.